Clareon TruPlus vs Tecnis Eyhance IOLs in Cataract Patients

NCT07658040 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2026-09-01

No results posted yet for this study

Summary

This study is a prospective, randomized, two-arm, single-center, single-surgeon, double-masked (subject and assessor) comparative study. It involves bilateral implantation of intraocular lenses (IOLs), comparing Clareon TruPlus IOL and Tecnis Eyhance IOLs in normal cataract patients. The study will be conducted at one site and will include a pre-operative visit and a 3-month post-operative assessment.

Conditions

  • Cataract

Interventions

DEVICE

Clareon TruPlus

Bilateral implantation

DEVICE

Tecnis Eyhance

Bilateral implantation

Sponsors & Collaborators

  • Sengi

    collaborator INDUSTRY
  • Gainesville Eye Associates

    lead OTHER

Principal Investigators

  • Clayton Blehm, MD · North Georgia Eye Associates

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-20
Primary Completion
2027-08-09
Completion
2027-08-09
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07658040 on ClinicalTrials.gov